# DESCRIPTION

## 1. INTRODUCTION

- introduce ATRX biomarker

## 2. BACKGROUND OF THE INVENTION

- discuss CDK4 inhibition therapies

## 3. SUMMARY OF THE INVENTION

- summarize ATRX biomarker invention

## 5. DETAILED DESCRIPTION OF THE INVENTION

- introduce ATRX biomarker

### 5.1 ATRX as a Biomarker

- define ATRX protein
- specify human ATRX protein sequence
- specify non-human ATRX protein sequences
- describe ATRX biomarker detection using antibodies
- define Responder Cells and Non-responder Cells
- describe ATRX biomarker detection in Responder Cells
- describe ATRX biomarker detection in Non-responder Cells
- define detectability of ATRX biomarker
- describe methods of ATRX detection

### 5.2 Anti-ATRX Antibodies

- define antibody
- describe antibody types
- introduce anti-ATRX antibodies
- describe antibody binding to ATRX
- exemplify anti-ATRX antibodies
- describe Ab1 antibody
- describe Ab2 antibody
- describe Ab3 antibody
- describe Ab4 antibody
- describe Ab5 antibody
- describe Ab6 antibody
- describe Ab7 antibody
- describe Ab8 antibody
- describe Ab9 antibody
- describe Ab10 antibody
- describe antibody production
- describe polyclonal antibody production
- describe monoclonal antibody production
- describe antibody testing

### 5.3 CDK4 Inhibitors

- introduce CDK4 inhibitors

### 5.4 Cancer Targets

- list cancer examples

### 5.5 Methods of Use

- define anti-cancer effect
- specify non-human subjects
- describe sample types
- define ATRX biomarker detection
- outline therapeutic methods
- introduce Bethyl antibody ('045 Ab)
- describe ATRX biomarker detection using '045 Ab
- outline treatment methods using '045 Ab
- introduce ATRX antibodies from section 5.2
- describe ATRX biomarker detection using ATRX antibodies
- outline treatment methods using ATRX antibodies
- specify phosphorylation and methylation detection
- describe alternative treatment modalities
- list ATM, ATR, and DNA-PK inhibitors
- introduce methods of use
- describe method for producing anti-cancer effect
- describe method for treating subject having cancer
- define "in combination with"
- describe step of collecting cancer cell sample
- introduce therapeutic methods using ATRX P-S2487 biomarker
- describe method for determining anti-cancer effect
- describe method for producing anti-cancer effect using ATRX P-S2487 biomarker
- describe method for treating subject having cancer using ATRX P-S2487 biomarker
- introduce assay for identifying modalities
- describe high-throughput screening method
- describe treatment of cells with CDK4 inhibitor
- describe treatment of cells with second modality
- describe determining number of ATRX foci per cell
- describe reference standard for ATRX foci
- describe immunohistochemistry for detecting ATRX foci
- describe assay for determining anti-cancer effect of CDK4 inhibitor

### 5.6 Kits

- define kit composition
- describe antibody preparation
- outline immunodetection reagents
- specify kit instructions

## 6. EXAMPLE 1

### 6.1 Materials and Methods

- perform immunoblot
- perform immunofluorescence

### 6.2 Results

- describe senescence and ALT
- measure ALT in responder and non-responder cells
- analyze ATRX protein expression
- correlate ATRX expression with senescence

### 6.3 Discussion

- discuss ATRX role in senescence
- propose ATRX mechanism in senescence

## 7. EXAMPLE 2

### Modified Form of ATRX in Non-Responder Cells

- detect ATRX with D5 antibody
- identify modified form of ATRX in non-responder cells

## 8. EXAMPLE 3

### ATRX Foci in Response to CDK4 Inhibition

- motivate ATRX foci analysis
- present results of ATRX foci analysis

### 9. EXAMPLE 4

- describe generation of anti-ATRX antibodies

### 10. REFERENCES

- list references related to ATRX
- list references related to chromatin remodeling
- list references related to telomere maintenance
- incorporate references by reference

